CN103110917A - Medicine for treating infantile eczema - Google Patents
Medicine for treating infantile eczema Download PDFInfo
- Publication number
- CN103110917A CN103110917A CN2013100594467A CN201310059446A CN103110917A CN 103110917 A CN103110917 A CN 103110917A CN 2013100594467 A CN2013100594467 A CN 2013100594467A CN 201310059446 A CN201310059446 A CN 201310059446A CN 103110917 A CN103110917 A CN 103110917A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- medicine
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating infantile eczema. The medicine is prepared from the following crude medical materials in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of radix angelicae, 5-15 parts of inula flower, 10-20 parts of akebia fruit, 1-20 parts of asparagus fern, 10-20 parts of pericarpium arecae, 10-20 parts of gecko, 1-20 parts of folium sennae, 10-20 parts of flos farfarae, 15-30 parts of scutellaria baicalensis, 10-20 parts of tetrapanax papyriferus, 10-30 parts of parasitic loranthusm, 15-30 parts of seed of garden balsam, 1-25 parts of rhizoma cyperi, 10-20 parts of fructus piperis longi, 20-30 parts of oriental wormwood, 1-20 parts of centella, 1-20 parts of notopterygium root, 1-20 parts of Japanese inula herb, 15-25 parts of cynanchum glaucescens and 1-20 parts of albizia flower. The medicine provided by the invention is reasonable in formula and explicit in curative effect, and can be used for effectively treating infantile eczema.
Description
Technical field
The present invention relates to pediatrics, specifically, relate to a kind of medicine for the treatment of infantile eczema.
Background technology
Infantile eczema is a kind of allergic skin disease, is exactly the anaphylaxis dermatosis of usually saying.Main cause be to ingestant, inhalation (inhalatio) or contactant do not tolerate or allergy due to.The child who suffers from eczema originally skin rubefaction, erythra appears, the skin that continues is sent out rough, desquamation, strokes child's skin as touching on sand paper.Chance heat, chance wet and all can make the eczema performance remarkable.
Therefore, the searching for the medicine of new treatment infantile eczema never stops.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of infantile eczema.
in order to realize purpose of the present invention, the invention provides a kind of medicine for the treatment of infantile eczema, it is to be made by weight by following bulk drugs: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Fructus Akebiae 10-20 part, Radix Asparagi 1-20 part, Pericarpium Arecae 10-20 part, Gecko 10-20 part, Folium Sennae 1-20 part, Flos Farfarae 10-20 part, Radix Scutellariae 15-30 part, Medulla Tetrapanacis 10-20 part, Herba Taxilli 10-30 part, Semen Impatientis 15-30 part, Rhizoma Cyperi 1-25 part, Fructus Piperis Longi 10-20 part, Herba Artemisiae Scopariae 20-30 part, Herba Centellae 1-20 part, Rhizoma Et Radix Notopterygii 1-20 part, Herba Inulae 1-20 part, Rhizoma Cynanchi Stauntonii 15-25 part and Flos Albiziae 1-20 part.
Preferably, the medicine for the treatment of infantile eczema of the present invention is to be made by weight by following bulk drugs: 19 parts of 8 parts of Radix Scrophulariaes, 16 parts of Rhizoma Zingiberiss, 23 parts of Fructus Corni, 17 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 7 parts of Flos Inulaes, 18 parts of Fructus Akebiae, 19 parts of Radix Asparagis, 12 parts of Pericarpium Arecae, 13 parts of Geckos, 11 parts of Folium Sennae, 14 parts of Flos Farfaraees, 25 parts of Radix Scutellariaes, 17 parts of Medulla Tetrapanaciss, 26 parts of Herba Taxillis, 27 parts of Semen Impatientis, 21 parts of Rhizoma Cyperis, 17 parts of Fructus Piperis Longi, 21 parts of Herba Artemisiae Scopariaes, 13 parts of Herba Centellaes, 15 parts of Rhizoma Et Radix Notopterygiis, 16 parts of Herba Inulae, 24 parts of Rhizoma Cynanchi Stauntoniis and Flos Albiziaes.
More preferably, described medicine can be made tablet, ointment, capsule or hard capsule.
The reasonable recipe of medicine of the present invention, curative effect is clear and definite, can effectively treat infantile eczema.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 ointment of the present invention
Get Radix Scrophulariae 8 grams, Rhizoma Zingiberis 16 grams, Fructus Corni 23 grams, Radix Platycodonis 17 grams, the Radix Angelicae Dahuricae 21 grams, Flos Inulae 7 grams, Fructus Akebiae 18 grams, Radix Asparagi 19 grams, Pericarpium Arecae 12 grams, Gecko 13 grams, Folium Sennae 11 grams, Flos Farfarae 14 grams, Radix Scutellariae 25 grams, Medulla Tetrapanacis 17 grams, Herba Taxilli 26 grams, Semen Impatientis 27 grams, Rhizoma Cyperi 21 grams, Fructus Piperis Longi 17 grams, Herba Artemisiae Scopariae 21 grams, Herba Centellae 13 grams, Rhizoma Et Radix Notopterygii 15 grams, Herba Inulae 16 grams, Rhizoma Cynanchi Stauntonii 24 grams and Flos Albiziae 19 grams, micronization is pulverized, cross 100 mesh sieves, mix homogeneously.Add liquid paraffin 60 grams and vaseline 800 grams in the powder of above-mentioned mixing, be stirred to and be even paste.
Experimental example
1.1 physical data
Choose 60 routine infantile eczema infants, male 30 examples, female's 30 examples; 2 months-2 years old age, 1.2 years old mean age, main clinical manifestation: each position skin rash of Head And Face and whole body, red pimple, erythema, little water scar, yellow squama and silly skin, ooze out, erosion.
Choosing the ointment of preparation in embodiment 1 treats.Used time, every place applied 30 grams with the ointment affected part of exterior coating, and every day 3 times, 7 days is 1 course for the treatment of, the other drug of stopping using during treatment.
Diagnostic criteria is as follows
Produce effects: erythra, red pimple, erythema, little water scar, yellow squama and silly skin, ooze out, the rotten to the corn disappearance, the visible sample of bran skin in a small amount desquamation; Effectively: affected part erythra, red pimple, erythema, little water scar, yellow squama and silly skin, ooze out, the rotten to the corn improvement; Invalid: symptom is without improvement.
Therapeutic outcome
Through the treatment of 1 course for the treatment of, to find whole infant erythra, red pimple, erythema, little water scar, yellow squama and silly skin, ooze out, the rotten to the corn disappearance, the visible sample of bran skin in a small amount desquamation all meets the standard of produce effects, and does not observe obvious untoward reaction.
Claims (3)
1. medicine for the treatment of infantile eczema, it is characterized in that, it is to be made by weight by following bulk drugs: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Fructus Akebiae 10-20 part, Radix Asparagi 1-20 part, Pericarpium Arecae 10-20 part, Gecko 10-20 part, Folium Sennae 1-20 part, Flos Farfarae 10-20 part, Radix Scutellariae 15-30 part, Medulla Tetrapanacis 10-20 part, Herba Taxilli 10-30 part, Semen Impatientis 15-30 part, Rhizoma Cyperi 1-25 part, Fructus Piperis Longi 10-20 part, Herba Artemisiae Scopariae 20-30 part, Herba Centellae 1-20 part, Rhizoma Et Radix Notopterygii 1-20 part, Herba Inulae 1-20 part, Rhizoma Cynanchi Stauntonii 15-25 part and Flos Albiziae 1-20 part.
2. the medicine for the treatment of infantile eczema according to claim 1, it is characterized in that, it is to be made by weight by following bulk drugs: 19 parts of 8 parts of Radix Scrophulariaes, 16 parts of Rhizoma Zingiberiss, 23 parts of Fructus Corni, 17 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 7 parts of Flos Inulaes, 18 parts of Fructus Akebiae, 19 parts of Radix Asparagis, 12 parts of Pericarpium Arecae, 13 parts of Geckos, 11 parts of Folium Sennae, 14 parts of Flos Farfaraees, 25 parts of Radix Scutellariaes, 17 parts of Medulla Tetrapanaciss, 26 parts of Herba Taxillis, 27 parts of Semen Impatientis, 21 parts of Rhizoma Cyperis, 17 parts of Fructus Piperis Longi, 21 parts of Herba Artemisiae Scopariaes, 13 parts of Herba Centellaes, 15 parts of Rhizoma Et Radix Notopterygiis, 16 parts of Herba Inulae, 24 parts of Rhizoma Cynanchi Stauntoniis and Flos Albiziaes.
3. the medicine for the treatment of infantile eczema according to claim 1 and 2, is characterized in that, described medicine can be made tablet, ointment, capsule or hard capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310059446.7A CN103110917B (en) | 2013-02-26 | 2013-02-26 | Medicine for treating infantile eczema |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310059446.7A CN103110917B (en) | 2013-02-26 | 2013-02-26 | Medicine for treating infantile eczema |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103110917A true CN103110917A (en) | 2013-05-22 |
| CN103110917B CN103110917B (en) | 2014-01-08 |
Family
ID=48409327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310059446.7A Expired - Fee Related CN103110917B (en) | 2013-02-26 | 2013-02-26 | Medicine for treating infantile eczema |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103110917B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104162077A (en) * | 2014-08-05 | 2014-11-26 | 李晓东 | Traditional Chinese medicine for treating infantile eczema |
| CN113924108A (en) * | 2019-07-15 | 2022-01-11 | 宝洁公司 | Topical skin care compositions comprising centella asiatica |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102258752A (en) * | 2011-07-25 | 2011-11-30 | 荣成市商贸城卫生所 | Chinese medicinal composition for treating eczema |
-
2013
- 2013-02-26 CN CN201310059446.7A patent/CN103110917B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102258752A (en) * | 2011-07-25 | 2011-11-30 | 荣成市商贸城卫生所 | Chinese medicinal composition for treating eczema |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104162077A (en) * | 2014-08-05 | 2014-11-26 | 李晓东 | Traditional Chinese medicine for treating infantile eczema |
| CN113924108A (en) * | 2019-07-15 | 2022-01-11 | 宝洁公司 | Topical skin care compositions comprising centella asiatica |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103110917B (en) | 2014-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101716273A (en) | Traditional Chinese medicine for treating dysmenorrhea | |
| CN101797298B (en) | Ointment for treating eczema and preparation method thereof | |
| CN103100075B (en) | Medicament for treating eczema | |
| CN101954058B (en) | Medicament for treating pernio | |
| CN103110917B (en) | Medicine for treating infantile eczema | |
| CN103142716B (en) | Chinese medicine external lotion for treating infantile eczema | |
| CN103800795A (en) | Traditional Chinese medicine for treating gastric ulcer | |
| CN102526578A (en) | Granular medicine for treating cold | |
| CN102302625B (en) | Medicament for treating infantile eczema | |
| CN102258691A (en) | Medicament for treating cancer and preparation method thereof | |
| CN102657839B (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN103893502A (en) | Traditional Chinese medicine for treating phlyctenular conjunctivitis | |
| CN102266451A (en) | Medicament for treating infantile eczema and preparation method thereof | |
| CN102302699A (en) | Tea for treating eczema | |
| CN102397371A (en) | Medicament for treating stomach illness | |
| CN102488802B (en) | Medicament for treating epidemic parotitis | |
| CN102370767A (en) | Traditional Chinese medicine formula used for treating intestinal obstruction | |
| CN104857303A (en) | Preparation method of medicine for treating infantile eczema | |
| CN103041088B (en) | Traditional Chinese medicine for treating qi-blood stasis type infertility | |
| CN102552511A (en) | Medicament for treating diarrhea | |
| CN103110919B (en) | Medicine for treating infantile diarrhea | |
| CN102526385A (en) | Medicament for treating climacteric syndrome | |
| CN102579789B (en) | Medicine for treating eczema | |
| CN102552590B (en) | Medicinal preparation for treating infantile diarrhea | |
| CN102631620B (en) | A kind of external application medicine for the treatment of gastropathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140108 Termination date: 20150226 |
|
| EXPY | Termination of patent right or utility model |